Premium
Healthcare supplements maker Bioplus Life Sciences Pvt. Ltd, which was a portfolio company for Asia-focused private equity firm AIF Capital until 2019, has been hovering on a revenue plateau for the last four fiscal years, primarily due to financial support provided to its loss-making subsidiary. The Bengaluru-headquartered firm, which markets most ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
